MGMT and glioblastoma: A recent study with a multicenter cohort of 96 glioblastoma patients [47] concluded that MGMT methylation may benefit overall survival only in patients with moderately vascularized glioblastomas, defined by MRI perfusion-based marker, such as relative cerebral blood volume (rCBV).